Salve Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 09-12-2024
- Paid Up Capital ₹ 1.45 M
as on 09-12-2024
- Company Age 18 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.97 Cr
as on 09-12-2024
- Satisfied Charges ₹ 3.11 M
as on 09-12-2024
- Revenue 31.33%
(FY 2022)
- Profit 20.05%
(FY 2022)
- Ebitda 96.32%
(FY 2022)
- Net Worth 21.54%
(FY 2022)
- Total Assets 39.76%
(FY 2022)
About Salve Pharmaceuticals
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.45 M.
The company currently has active open charges totaling ₹5.97 Cr. The company has closed loans amounting to ₹3.11 M, as per Ministry of Corporate Affairs (MCA) records.
Ajay Kakar and Archana Kakar serve as directors at the Company.
- CIN/LLPIN
U24232DL2006PTC145607
- Company No.
145607
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Jan 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Salve Pharmaceuticals Private Limited offer?
Salve Pharmaceuticals Private Limited offers a wide range of products and services, including Cosmetics, Hair & Beauty Products, Eye Cosmetic, Flavours & Aromatics, Food Additive, Skin Care Cosmetics, Lip Cosmetics, Sunscreen, Body Care Products, Body Lotions, Common Disease Medicines.
Who are the key members and board of directors at Salve Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajay Kakar  | Director | 31-Jan-2006 | Current |
| Archana Kakar | Director | 31-Jan-2006 | Current |
Financial Performance of Salve Pharmaceuticals.
Salve Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 31.33% increase. The company also saw a substantial improvement in profitability, with a 20.05% increase in profit. The company's net worth Soared by an impressive increase of 21.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Salve Pharmaceuticals?
Unlock access to Salve Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Salvia Cosmeceuticals Private LimitedActive 14 years 4 monthsAjay Kakar and Archana Kakar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Jul 2024 | ₹5.94 M | Open |
Others Creation Date: 06 Jul 2022 | ₹3.51 Cr | Open |
Others Creation Date: 08 Apr 2011 | ₹1.87 Cr | Open |
How Many Employees Work at Salve Pharmaceuticals?
Salve Pharmaceuticals has a workforce of 94 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Salve Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Salve Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
